Company / Profit Margin
NewAmsterdam Pharma Co N.V. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-905.7%
FY2025
5-year range
-1255.8% / -22.0%
FY2022-FY2025
Trend
-70.8%
vs FY2024
Sector context
#130 of 146
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s profit margin of -905.7% is lower than 89% of companies in the Health Care sector (FY2025). Improved from -1255.8% to -905.7% over the past 2 years.
Based on SEC 10-K filings.
-905.7% in FY2025 with a 3-year CAGR of -883.7%.
Improved from -1255.8% to -905.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -883.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 146This company -905.7% Sector average -796.3%
▼
-13.7% below sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 70.8% year-over-year.
- Currently 109.5pp below the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -905.7% | -70.8% |
| FY2024 | -530.3% | +57.8% |
| FY2023 | -1255.8% | -5597.6% |
| FY2022 | -22.0% | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026